National Bank of Canada’s GoHealth GOCO Stock Holding History

National Bank of Canada’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-61,034	Closed	-$3.47M	–	2915
2021 Q4	$3.47M	Buy	+61,034	New	+$4.07M	0.01%	661

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

National Bank of Canada's GOCO Position: Q1 2022 in Review

National Bank of Canada sold out of GoHealth (GOCO) in Q1 2022, closing a stake of 61,034 shares — an estimated $3.47M sold.

National Bank of Canada first reported a position in GOCO in Q4 2021 and held it in 1 quarter. The position peaked at $3.47M in Q4 2021. 112 funds tracked by Wall St. Rank hold GOCO as of Q1 2022.

National Bank of Canada reported no remaining GoHealth position as of Q1 2022 after selling out during the quarter.
National Bank of Canada sold 61,034 GoHealth shares in Q1 2022, an estimated $3.47M.
National Bank of Canada first reported a position in GoHealth in Q4 2021 and held it in 1 quarter.
National Bank of Canada's GoHealth position peaked at $3.47M in Q4 2021.
112 funds tracked by Wall St. Rank held GoHealth as of Q1 2022.

Based on National Bank of Canada's 13F filing for Q1 2022, filed 5 May 2022.